Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
16.06.2025 11:41:33

Kumho Mitsui Chemicals Begins Operation of Chlor-Alkali Plant Using thyssenkrupp nucera Technology


EQS-Media / 16.06.2025 / 11:41 CET/CEST

Kumho Mitsui Chemicals Begins Operation of Chlor-Alkali Plant Using thyssenkrupp nucera Technology

  • Utilizing latest generation e-BiTAC v7 electrolyzers, thyssenkrupp nucera designed and supplied a chlor-alkali plant for Kumho Mitsui Chemicals (KMCI) in Yeosu, South Korea
  • KMCI uses produced chlorine to replace imports of this raw material and to expand its Methylene Diphenyl Diisocyanate (MDI) production capacity
  • New chlor-alkali plant also enables KMCI to recycle by-product brine from MDI production and to reduce its environmental footprint

Dortmund, Tokyo, June 16, 2025 – Kumho Mitsui Chemicals (KMCI) has enhanced its production process of Methylene Diphenyl Diisocyanate (MDI) by utilizing the latest generation e-BiTAC v7 electrolyzer technology from thyssenkrupp nucera. The supplier of world-leading technologies for high-efficiency electrolysis plants designed and supplied a chlor-alkali plant for KMCI in Yeosu, South Korea with a capacity of 60,000 tons per year of chlorine production. Recently, the operation of the plant has been started successfully.

KMCI, a South Korean petrochemical company and a world-leading polyurethane maker, will use the produced chlorine for MDI production – replacing imported raw material of chlorine. MDI is an essential raw material for production of Spandex, TPU (Thermoplastic polyurethane), synthetic leather, shoes, paints, coating, adhesives, and various elastomers.

Furthermore, the chlor-alkali plant will recycle by-product brine from MDI production which is usually discharged as effluent. This enables KMCI to comply with stringent environmental regulations on industrial effluent in a cost effective manner and to reduce their environmental footprint. “The start-up of our new chlor-alkali plant is an important step to expand our production capacities and to secure an independent supply of MDI without importing chlorine. It also underlines our commitment to supplying eco-friendly products,” says Kwon Hyung Seob General Manager of KMCI.

thyssenkrupp nucera initially supplied a lab cell facility as a pilot test and verified the technical feasibility for operating the chlor-alkali plant with waste brine from MDI process. Afterwards, in 2021, the electrolyzer specialist was awarded an EP contract to design and supply the entire chlor-alkali plant. “Once again, our proven electrolysis technology made an important contribution to our clients’ path to improve their production processes and reduce their environmental footprint. By recycling by-product brine, KMCI and thyssenkrupp nucera have jointly addressed one of the major concerns of the polyurethane industry,” says Akira Shigeta, CEO of thyssenkrupp nucera Japan. 

Photos:
If you require photos, please contact us.
 

Media inquiries:  
Rita Syre 
Senior Manager Media Relations and Financial Communications  
Phone: +49 174 161 86 24 
E-Mail: rita.syre@thyssenkrupp-nucera.com

Investor inquiries:  
Dr. Hendrik Finger'
Head of Investor Relations
Phone: +49 231 229 724 347
Mail: hendrik.finger@thyssenkrupp-nucera.com

 

About thyssenkrupp nucera:  
thyssenkrupp nucera offers world-leading technologies for highly efficient electrolysis plants. The company has extensive expertise in the design, procurement, and construction of electrochemical plants. Its track record includes more than 600 successfully installed projects with a total capacity of more than 10 gigawatts. thyssenkrupp nucera's chlor-alkali electrolysis plants allow significant savings in construction costs and offer fast, simple, and cost-effective assembly. thyssenkrupp nucera successfully made an IPO in July 2023 and is a member of the SDAX of the Frankfurt Stock Exchange. 

www.thyssenkrupp-nucera.com



End of Media Release


Issuer: thyssenkrupp nucera AG & Co. KGaA
Key word(s): Industry

16.06.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN: DE000NCA0001
WKN: NCA000
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2155772

 
End of News EQS Media

2155772  16.06.2025 CET/CEST

Analysen zu thyssenkrupp nucera AG & Co. KGaA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
04.06.25 thyssenkrupp nucera Outperform RBC Capital Markets
04.06.25 thyssenkrupp nucera Buy Deutsche Bank AG
16.05.25 thyssenkrupp nucera Buy Deutsche Bank AG
15.05.25 thyssenkrupp nucera Outperform RBC Capital Markets
13.05.25 thyssenkrupp nucera Outperform RBC Capital Markets
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen.

Themen im Video:
🔹 Merck & Co. (USA) – Probleme mit Impfstoffen und Patentlaufzeiten
🔹 Pfizer – Wachstumsdruck durch auslaufende Patente
🔹 United Health – Ermittlungen und steigende Gesundheitskosten
🔹 Novo Nordisk – Abnehmspritze, Wettbewerb und Marktkorrektur
🔹 Nike – Konsumflaute und neue Konkurrenz
🔹 Estée Lauder – Kursabsturz, China-Schwäche und Hoffnung auf Turnaround
🔹 Campbell Soup – Value-Aktie mit attraktiver Dividende
🔹 Regeneron – Erfolgreiche Gründerstory mit Herausforderungen

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’529.65 19.09 BKISYU
Short 12’759.26 13.90 U80SSU
Short 13’251.80 8.91 B7ZS2U
SMI-Kurs: 12’007.06 17.06.2025 17:31:26
Long 11’499.81 18.79 BAES3U
Long 11’256.34 13.67 BRTSZU
Long 10’762.58 8.75 BPDSHU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}